Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000902664-20-002925
Filing Date
2020-08-10
Accepted
2020-08-10 08:30:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 CORMEDIX INC. p20-1496sc13d.htm SC 13D 54590
  Complete submission text file 0000902664-20-002925.txt   56118
Mailing Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922
Business Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Subject) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85411 | Film No.: 201087240
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40 WEST 57TH STREET 4TH FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH STREET 4TH FLOOR NEW YORK NY 10019 212-974-6000
Elliott Investment Management L.P. (Filed by) CIK: 0001791786 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D